×
Sol-Gel Technologies EBIT 2016-2024 | SLGL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sol-Gel Technologies ebit from 2016 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Sol-Gel Technologies EBIT 2016-2024 | SLGL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sol-Gel Technologies ebit from 2016 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$24.9B
Dr Reddy's Laboratories (RDY)
$12.6B
BridgeBio Pharma (BBIO)
$6.8B
Bausch Health Cos (BHC)
$2.8B
Supernus Pharmaceuticals (SUPN)
$2.1B
Amphastar Pharmaceuticals (AMPH)
$1.7B
Personalis (PSNL)
$396M
Taysha Gene Therapies (TSHA)
$314M
Assembly Biosciences (ASMB)
$95M
Evoke Pharma (EVOK)
$6M
Teligent (TLGT)
$0M